Notes / Company

Wockhardt Ltd.

WOCKPHARMA BSE 532300 ISIN INE049B01025 Pharmaceuticals

Fundamentals

Market cap: ₹25,599 cr
P/E: 80.75×
ROE: 0.00%
Debt / equity: 0.43
52-week range: 1086.70 — 1868.80

Research on Tijori Finance

The timeline — 1 note on Wockhardt Ltd.

May 2026

21 May 26 · 14:42 IST Brief

Brief · Credit

Wockhardt's credit quality just improved — but the market already knew

ICRA upgraded the pharma company to A- (Stable) from BBB (Positive), reflecting better finances and market position. The move was widely anticipated.

Verify on exchange BSE filings for WOCKPHARMA NSE filings for WOCKPHARMA Tijori Finance company page